TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF

A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FUJIOKA SHINGO, SHIOZAKI MAKOTO, MATSUO TAKUYA, OBIKA SHINGO, SHINAGAWA YUKO, IKENOGAMI TAKU, YAMANAKA HIROSHI, MAEDA KATSUYA, KOTOKU MASAYUKI, MAEBA TAKAKI, NOJI SATORU, DOI SATOKI, ITO KEISUKE, SAKAI TAKAYUKI, SUWA YOSHIHIRO, HIRASHIMA SHINTARO, YOKOTA MASAHIRO, HARA YOSHINORI, HIRATA KAZUYUKI, OKA TAKAHIRO, SEKI NORIYOSHI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FUJIOKA SHINGO
SHIOZAKI MAKOTO
MATSUO TAKUYA
OBIKA SHINGO
SHINAGAWA YUKO
IKENOGAMI TAKU
YAMANAKA HIROSHI
MAEDA KATSUYA
KOTOKU MASAYUKI
MAEBA TAKAKI
NOJI SATORU
DOI SATOKI
ITO KEISUKE
SAKAI TAKAYUKI
SUWA YOSHIHIRO
HIRASHIMA SHINTARO
YOKOTA MASAHIRO
HARA YOSHINORI
HIRATA KAZUYUKI
OKA TAKAHIRO
SEKI NORIYOSHI
description A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2016137639A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2016137639A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2016137639A13</originalsourceid><addsrcrecordid>eNrjZDAOCfJ0jPL3cdX1DPaPALMUnP19A_xD_VwUHIHY19XF09nRRyE02FUhxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcGGxkYmhkam5sZWzoaGhOnCgBRhygw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF</title><source>esp@cenet</source><creator>FUJIOKA SHINGO ; SHIOZAKI MAKOTO ; MATSUO TAKUYA ; OBIKA SHINGO ; SHINAGAWA YUKO ; IKENOGAMI TAKU ; YAMANAKA HIROSHI ; MAEDA KATSUYA ; KOTOKU MASAYUKI ; MAEBA TAKAKI ; NOJI SATORU ; DOI SATOKI ; ITO KEISUKE ; SAKAI TAKAYUKI ; SUWA YOSHIHIRO ; HIRASHIMA SHINTARO ; YOKOTA MASAHIRO ; HARA YOSHINORI ; HIRATA KAZUYUKI ; OKA TAKAHIRO ; SEKI NORIYOSHI</creator><creatorcontrib>FUJIOKA SHINGO ; SHIOZAKI MAKOTO ; MATSUO TAKUYA ; OBIKA SHINGO ; SHINAGAWA YUKO ; IKENOGAMI TAKU ; YAMANAKA HIROSHI ; MAEDA KATSUYA ; KOTOKU MASAYUKI ; MAEBA TAKAKI ; NOJI SATORU ; DOI SATOKI ; ITO KEISUKE ; SAKAI TAKAYUKI ; SUWA YOSHIHIRO ; HIRASHIMA SHINTARO ; YOKOTA MASAHIRO ; HARA YOSHINORI ; HIRATA KAZUYUKI ; OKA TAKAHIRO ; SEKI NORIYOSHI</creatorcontrib><description>A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160519&amp;DB=EPODOC&amp;CC=US&amp;NR=2016137639A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160519&amp;DB=EPODOC&amp;CC=US&amp;NR=2016137639A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FUJIOKA SHINGO</creatorcontrib><creatorcontrib>SHIOZAKI MAKOTO</creatorcontrib><creatorcontrib>MATSUO TAKUYA</creatorcontrib><creatorcontrib>OBIKA SHINGO</creatorcontrib><creatorcontrib>SHINAGAWA YUKO</creatorcontrib><creatorcontrib>IKENOGAMI TAKU</creatorcontrib><creatorcontrib>YAMANAKA HIROSHI</creatorcontrib><creatorcontrib>MAEDA KATSUYA</creatorcontrib><creatorcontrib>KOTOKU MASAYUKI</creatorcontrib><creatorcontrib>MAEBA TAKAKI</creatorcontrib><creatorcontrib>NOJI SATORU</creatorcontrib><creatorcontrib>DOI SATOKI</creatorcontrib><creatorcontrib>ITO KEISUKE</creatorcontrib><creatorcontrib>SAKAI TAKAYUKI</creatorcontrib><creatorcontrib>SUWA YOSHIHIRO</creatorcontrib><creatorcontrib>HIRASHIMA SHINTARO</creatorcontrib><creatorcontrib>YOKOTA MASAHIRO</creatorcontrib><creatorcontrib>HARA YOSHINORI</creatorcontrib><creatorcontrib>HIRATA KAZUYUKI</creatorcontrib><creatorcontrib>OKA TAKAHIRO</creatorcontrib><creatorcontrib>SEKI NORIYOSHI</creatorcontrib><title>TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF</title><description>A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOCfJ0jPL3cdX1DPaPALMUnP19A_xD_VwUHIHY19XF09nRRyE02FUhxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcGGxkYmhkam5sZWzoaGhOnCgBRhygw</recordid><startdate>20160519</startdate><enddate>20160519</enddate><creator>FUJIOKA SHINGO</creator><creator>SHIOZAKI MAKOTO</creator><creator>MATSUO TAKUYA</creator><creator>OBIKA SHINGO</creator><creator>SHINAGAWA YUKO</creator><creator>IKENOGAMI TAKU</creator><creator>YAMANAKA HIROSHI</creator><creator>MAEDA KATSUYA</creator><creator>KOTOKU MASAYUKI</creator><creator>MAEBA TAKAKI</creator><creator>NOJI SATORU</creator><creator>DOI SATOKI</creator><creator>ITO KEISUKE</creator><creator>SAKAI TAKAYUKI</creator><creator>SUWA YOSHIHIRO</creator><creator>HIRASHIMA SHINTARO</creator><creator>YOKOTA MASAHIRO</creator><creator>HARA YOSHINORI</creator><creator>HIRATA KAZUYUKI</creator><creator>OKA TAKAHIRO</creator><creator>SEKI NORIYOSHI</creator><scope>EVB</scope></search><sort><creationdate>20160519</creationdate><title>TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF</title><author>FUJIOKA SHINGO ; SHIOZAKI MAKOTO ; MATSUO TAKUYA ; OBIKA SHINGO ; SHINAGAWA YUKO ; IKENOGAMI TAKU ; YAMANAKA HIROSHI ; MAEDA KATSUYA ; KOTOKU MASAYUKI ; MAEBA TAKAKI ; NOJI SATORU ; DOI SATOKI ; ITO KEISUKE ; SAKAI TAKAYUKI ; SUWA YOSHIHIRO ; HIRASHIMA SHINTARO ; YOKOTA MASAHIRO ; HARA YOSHINORI ; HIRATA KAZUYUKI ; OKA TAKAHIRO ; SEKI NORIYOSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2016137639A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>FUJIOKA SHINGO</creatorcontrib><creatorcontrib>SHIOZAKI MAKOTO</creatorcontrib><creatorcontrib>MATSUO TAKUYA</creatorcontrib><creatorcontrib>OBIKA SHINGO</creatorcontrib><creatorcontrib>SHINAGAWA YUKO</creatorcontrib><creatorcontrib>IKENOGAMI TAKU</creatorcontrib><creatorcontrib>YAMANAKA HIROSHI</creatorcontrib><creatorcontrib>MAEDA KATSUYA</creatorcontrib><creatorcontrib>KOTOKU MASAYUKI</creatorcontrib><creatorcontrib>MAEBA TAKAKI</creatorcontrib><creatorcontrib>NOJI SATORU</creatorcontrib><creatorcontrib>DOI SATOKI</creatorcontrib><creatorcontrib>ITO KEISUKE</creatorcontrib><creatorcontrib>SAKAI TAKAYUKI</creatorcontrib><creatorcontrib>SUWA YOSHIHIRO</creatorcontrib><creatorcontrib>HIRASHIMA SHINTARO</creatorcontrib><creatorcontrib>YOKOTA MASAHIRO</creatorcontrib><creatorcontrib>HARA YOSHINORI</creatorcontrib><creatorcontrib>HIRATA KAZUYUKI</creatorcontrib><creatorcontrib>OKA TAKAHIRO</creatorcontrib><creatorcontrib>SEKI NORIYOSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FUJIOKA SHINGO</au><au>SHIOZAKI MAKOTO</au><au>MATSUO TAKUYA</au><au>OBIKA SHINGO</au><au>SHINAGAWA YUKO</au><au>IKENOGAMI TAKU</au><au>YAMANAKA HIROSHI</au><au>MAEDA KATSUYA</au><au>KOTOKU MASAYUKI</au><au>MAEBA TAKAKI</au><au>NOJI SATORU</au><au>DOI SATOKI</au><au>ITO KEISUKE</au><au>SAKAI TAKAYUKI</au><au>SUWA YOSHIHIRO</au><au>HIRASHIMA SHINTARO</au><au>YOKOTA MASAHIRO</au><au>HARA YOSHINORI</au><au>HIRATA KAZUYUKI</au><au>OKA TAKAHIRO</au><au>SEKI NORIYOSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF</title><date>2016-05-19</date><risdate>2016</risdate><abstract>A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2016137639A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T05%3A35%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FUJIOKA%20SHINGO&rft.date=2016-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2016137639A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true